Omicron News and Research

RSS

Evaluating effectiveness of various COVID-19 vaccine doses after primary vaccination

First boosters, second boosters, monovalent, bivalent. Just like the SARS-CoV-2 virus strain, the vaccines to combat the virus are always changing—and perhaps confusing.

2 Feb 2024

Immunocompromised patients show prolonged SARS-CoV-2 infection and unique mutations

study identifies risk factors for prolonged SARS-CoV-2 infection in immunocompromised patients, revealing that B-cell dysfunction, solid organ transplantation, and AIDS lead to longer infections and unique spike mutations.

31 Jan 2024

Neonates exposed to SARS-CoV-2 in utero at higher risk of respiratory distress, study finds

Researchers found that neonates born to mothers with SARS-CoV-2 infection face an increased risk of respiratory distress, potentially due to an inflammatory response triggered by prenatal exposure.

29 Jan 2024

Study offers insights into who's at risk for long COVID among immunocompromised patients

Early in the pandemic, clinicians noticed that certain immunocompromised patients were experiencing persistent SARS-CoV-2 infections, some lasting weeks to months at a time.

26 Jan 2024

UK Biobank research reveals significant impact of type 2 diabetes on COVID-19 outcomes

How type 2 diabetes and genetic susceptibility to the disease impacted the severity of and mortality risk associated with coronavirus disease 2019.

26 Jan 2024

Balancing efficacy and safety: The challenges of mRNA drugs and vaccines in modern medicine

Researchers analyzed the toxicity concerns and advancements in mRNA therapeutics, focusing on their cellular toxicity, reactogenicity, and distribution, and discussed the challenges and benefits of mRNA research.

24 Jan 2024

UKHSA unveils groundbreaking Pathogen Genomics Strategy for pandemic preparedness

The UK Health Security Agency (UKHSA) has today published its Pathogen Genomics Strategy, laying out a 5 year plan for the organization's role in the wider delivery of pathogen genomics to prepare for and respond to infectious disease threats to public health.

24 Jan 2024

Effects of varying COVID-19 vaccination rates on population-level health outcomes across variant waves in the U.S.

23 Jan 2024

Study assesses effectiveness of strategies to prevent SARS-CoV-2 transmission in healthcare settings

Researchers analyzed whether infection prevention measures during the COVID-19 pandemic were adequate in protecting healthcare workers.

22 Jan 2024

Memory T cells learn and adapt: Post-Omicron immunity offers wider protection

It has been 4 years since the start of the COVID-19 pandemic. SARS-CoV-2 has yet to be eradicated and new variants are continuously emerging.

19 Jan 2024

Study shows Omicron variants evade immune system like predecessors, suggesting key evolutionary trait in SARS-CoV-2

Researchers compared SARS-CoV-2 Omicron variant of concern replication in human cell lines and primary airway cultures and measured host responses to infection.

19 Jan 2024

New study reveals flaws in AI tools used for SARS-CoV-2 antibody discovery

A discovery program for SARS-CoV-2-nABs potentially targeting its resistant strains.

19 Jan 2024

COVID-19 vaccines saved over 1.4 million lives across Europe, WHO study reveals

A study analyzing COVID-19 mortality and vaccination data in Europe from December 2020 to March 2023 found that vaccination efforts reduced the death toll by 57%, saving approximately 1.4 million lives, with the most significant impact observed in older individuals and during the Omicron variant surge.

17 Jan 2024

Study reveals intestinal helminth infection diminishes T cell response to COVID-19 mRNA vaccine

Study investigates the impact of helminth infection on COVID-19 mRNA vaccine efficacy, revealing that while antibody responses remain largely unaffected, T-cell responses are significantly impaired, particularly against Omicron variants.

17 Jan 2024

COVID-19 vaccines show moderate success in preventing long COVID in kids

Study reveals that COVID-19 vaccines moderately reduce the risk of long COVID in children, with higher effectiveness observed in adolescents compared to younger children.

17 Jan 2024

Comprehensive analysis of more than 2 million SARS-CoV-2 samples detects co-infections and intra-host recombination

Researchers evaluated the prevalence of co-infection and intra-host recombination in over 2 million global SARS-CoV-2 cases and developed strategies for accurate identification and analysis of recombinant strains.

17 Jan 2024

New Omicron variants relearn immunity dodging tricks

Recent SARS-CoV-2 variants such as BA.4 and BA.5 developed abilities missing from the first Omicron variants that allowed them to overcome humans' innate immunity, according to research from UCL.

16 Jan 2024

Simple measures in the health care setting could prevent SARS-CoV-2 transmission

In early 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a highly contagious and pathogenic virus, made its alarming debut and quickly spread worldwide, causing the novel coronavirus (COVID-19) pandemic that threatened human health and public safety.

16 Jan 2024

mRNA COVID-19 vaccines highly effective in preventing hospitalizations among adolescents in Nordic study

Study evaluated the effectiveness of mRNA COVID-19 vaccines (BNT162b2, mRNA-1273, and heterologous schedules) in preventing hospitalization among adolescents in Nordic countries, finding high protection rates of 73% to 86% at six months.

14 Jan 2024

Paxlovid treatment in 20% of COVID-19 patients could avert 850,000 hospitalizations, save up to $170 billion

A study in the Emerging Infectious Diseases journal shows treating 20% of COVID-19 patients with Paxlovid could save up to 0.85 million lives and reduce the economic burden by US $170.17 billion in the US.

14 Jan 2024

Omicron News and Research

Evaluating effectiveness of various COVID-19 vaccine doses after primary vaccination

Immunocompromised patients show prolonged SARS-CoV-2 infection and unique mutations

Neonates exposed to SARS-CoV-2 in utero at higher risk of respiratory distress, study finds

Study offers insights into who's at risk for long COVID among immunocompromised patients

UK Biobank research reveals significant impact of type 2 diabetes on COVID-19 outcomes

Balancing efficacy and safety: The challenges of mRNA drugs and vaccines in modern medicine

UKHSA unveils groundbreaking Pathogen Genomics Strategy for pandemic preparedness

Effects of varying COVID-19 vaccination rates on population-level health outcomes across variant waves in the U.S.

Study assesses effectiveness of strategies to prevent SARS-CoV-2 transmission in healthcare settings

Memory T cells learn and adapt: Post-Omicron immunity offers wider protection

Study shows Omicron variants evade immune system like predecessors, suggesting key evolutionary trait in SARS-CoV-2

New study reveals flaws in AI tools used for SARS-CoV-2 antibody discovery

COVID-19 vaccines saved over 1.4 million lives across Europe, WHO study reveals

Study reveals intestinal helminth infection diminishes T cell response to COVID-19 mRNA vaccine

COVID-19 vaccines show moderate success in preventing long COVID in kids

Comprehensive analysis of more than 2 million SARS-CoV-2 samples detects co-infections and intra-host recombination

New Omicron variants relearn immunity dodging tricks

Simple measures in the health care setting could prevent SARS-CoV-2 transmission

mRNA COVID-19 vaccines highly effective in preventing hospitalizations among adolescents in Nordic study

Paxlovid treatment in 20% of COVID-19 patients could avert 850,000 hospitalizations, save up to $170 billion

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News